Basophil CD203c Levels Are Increased at Baseline and Can Be Used to Monitor Omalizumab Treatment in Subjects with Nut Allergy

By  

International Archives of Allergy and Immunology, Vol. 154, Iss. 4, 2010-10 ,pp. : 318-327

Karger

Access to resources Recommend Favorite

Pre‐treatment by omalizumab allows allergen immunotherapy in children and young adults with severe allergic asthma

By  

PEDIATRIC ALLERGY AND IMMUNOLOGY, Vol. 25, Iss. 8, 2014-12 ,pp. : 829-832

John Wiley & Sons Inc

Access to resources Recommend Favorite

A step‐down protocol for omalizumab treatment in oral corticosteroid‐dependent allergic asthma patients

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 84, Iss. 2, 2018-02 ,pp. : 339-348

John Wiley & Sons Inc

Access to resources Recommend Favorite

Patient-related factors in rhinitis and asthma: the satisfaction with allergy treatment survey

By Ciprandi Giorgio   Incorvaia Cristoforo   Scurati Silvia   Puccinelli Paola   Soffia Silvia   Frati Franco   Rossi Oliviero  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1005-1011

Informa Healthcare

Access to resources Recommend Favorite

Effect of omalizumab on the need for rescue systemic corticosteroid treatment in patients with moderate-to-severe persistent IgE-mediated allergic asthma: a pooled analysis

By Busse William W.   Massanari Marc   Kianifard Farid   Geba Gregory P.  

Current Medical Research and Opinion, Vol. 23, Iss. 10, 2007-10 ,pp. : 2379-2386

Informa Healthcare

Access to resources Recommend Favorite